-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTAY THERAPEUTICS CLOSES $37 MILLION SERIES A FINANCING TO ADVANCE FIRST ORAL DUX4 INHIBITOR FOR FSHD INTO THE CLINIC

Reuters·10/14/2026 12:02:13